{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T20:50:07Z","timestamp":1784062207695,"version":"3.55.0"},"reference-count":18,"publisher":"Elsevier BV","issue":"39","license":[{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1016\/j.vaccine.2014.07.020","type":"journal-article","created":{"date-parts":[[2014,7,18]],"date-time":"2014-07-18T22:00:35Z","timestamp":1405720835000},"page":"5000-5005","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Active surveillance of adverse events following childhood immunization in Singapore"],"prefix":"10.1016","volume":"32","author":[{"given":"Koh Cheng","family":"Thoon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sally Bee Leng","family":"Soh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Woei Kang","family":"Liew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arunan","family":"Gunachandran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie Woon Hui","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia Yin","family":"Chong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chee Fu","family":"Yung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2014.07.020_bib0005","series-title":"State of the world's vaccines and immunization","author":"World Health Organization","year":"2009"},{"key":"10.1016\/j.vaccine.2014.07.020_bib0010","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1016\/j.vaccine.2004.01.010","article-title":"A global perspective on vaccine safety","volume":"2001","author":"Duclos","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.07.020_bib0015","series-title":"WHO\/Europe launches plan for accelerated action to eliminate measles and rubella","author":"World Health Organization","year":"2013"},{"key":"10.1016\/j.vaccine.2014.07.020_bib0020","series-title":"HSA's role in the regulation of Western medicines in Singapore","author":"Health Science Authority","year":"2012"},{"key":"10.1016\/j.vaccine.2014.07.020_bib0025","first-page":"301","article-title":"Strategic Advisory Group of Experts on Immunization\u2014report of the extraordinary meeting on the influenza A(H1N1) 2009 pandemic, 7 July 2009","volume":"84","author":"World Health Organization","year":"2009","journal-title":"Wkly. Epidemiol. Rec."},{"key":"10.1016\/j.vaccine.2014.07.020_bib0030","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S1045-1870(03)00036-0","article-title":"Immunization monitoring program, active: a model of active surveillance of vaccine safety","volume":"14","author":"Scheifele","year":"2003","journal-title":"Sem Pediatr Infect Dis"},{"key":"10.1016\/j.vaccine.2014.07.020_bib0035","series-title":"Population trends","author":"Singapore Department of Statistics","year":"2013"},{"key":"10.1016\/j.vaccine.2014.07.020_bib0040","series-title":"Hospital admission rates by age and sex","author":"Ministry of Health Singapore","year":"2012"},{"key":"10.1016\/j.vaccine.2014.07.020_bib0045","series-title":"Contact Singapore, Healthcare in Singapore","author":"Singapore Economic Development Board and Ministry of Manpower","year":"2013"},{"key":"10.1016\/j.vaccine.2014.07.020_bib0050","series-title":"National immunisation registry","author":"Health Promotion Board","year":"2007"},{"key":"10.1016\/j.vaccine.2014.07.020_bib0055","series-title":"WHO-UMC causality assessment","author":"Uppsala Monitoring Centre","year":"2013"},{"key":"10.1016\/j.vaccine.2014.07.020_bib0060","series-title":"Open source epidemiologic statistics for public health, version 3.0.1","author":"Dean","year":"2013"},{"key":"10.1016\/j.vaccine.2014.07.020_bib0065","series-title":"Reports of lymphadenitis following administration of BCG Vaccine SSI\u00ae","first-page":"31","volume":"13","author":"Health Science Authority","year":"2011"},{"key":"10.1016\/j.vaccine.2014.07.020_bib0070","first-page":"93","article-title":"Quality control of BCG vaccine by WHO: a review of factors that may influence vaccine effectiveness and safety","volume":"68","author":"Milstien","year":"1990","journal-title":"Bull World Health Org"},{"key":"10.1016\/j.vaccine.2014.07.020_bib0075","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1016\/j.vaccine.2008.11.035","article-title":"Guidelines for collection, analysis and presentation of vaccine safety data in surveillance systems","volume":"27","author":"Bonhoeffer","year":"2009","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2014.07.020_bib0080","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.biologicals.2012.07.007","article-title":"Current status and future directions of post-marketing vaccine safety monitoring with focus on USA and Europe","volume":"40","author":"Bonhoeffer","year":"2012","journal-title":"Biologicals"},{"issue":"10 suppl 2","key":"10.1016\/j.vaccine.2014.07.020_bib0085","doi-asserted-by":"crossref","first-page":"S89","DOI":"10.1097\/MLR.0b013e3180616c0a","article-title":"Real-time vaccine safety surveillance for the early detection of adverse events","volume":"45","author":"Lieu","year":"2007","journal-title":"Med. Care"},{"key":"10.1016\/j.vaccine.2014.07.020_bib0090","series-title":"User manual for the revised WHO AEFI causality assessment classification","article-title":"Causality assessment of an adverse event following immunization (AEFI)","author":"World Health Organization","year":"2013"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X14009463?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X14009463?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T13:50:03Z","timestamp":1538401803000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X14009463"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9]]},"references-count":18,"journal-issue":{"issue":"39","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["S0264410X14009463"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2014.07.020","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Active surveillance of adverse events following childhood immunization in Singapore","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2014.07.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}